icon-folder.gif   Conference Reports for NATAP  
 
  15th International Workshop on
Clinical Pharmacology
of HIV and Hepatitis Therapy
May 19- 21, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics and Safety of Hepatitis C Virus
Nonstructural Protein 5A Inhibitor MK-8742 in
Cirrhotic Patients With Mild and Moderate Hepatic Insufficiency

 
 
  Reported by Jules Levin
 
15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, Washington DC; May 19-21, 2014
 
WL Marshall1, G Garrett1, WW Yeh1, L Caro1, H-P Feng1, X Huang1, KC Lasseter2, RA Preston3, T Marbury4 and JR Butterton1 1Merck & Co. Inc, Whitehouse Station NJ, USA, 2Clinical Pharmacology of Miami, Miami, FL, USA, 3Division of Clinical Pharmacology, Miller School of Medicine, University of Miami, FL USA, and 4Orlando Clinical Research Center, Orlando, FL, USA

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif